These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29059176)

  • 21. Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach.
    Kaba D; Koffi M; Kouakou L; N'Gouan EK; Djohan V; Courtin F; N'Djetchi MK; Coulibaly B; Adingra GP; Berté D; Ta BTD; Koné M; Traoré BM; Sutherland SA; Crump RE; Huang CI; Madan J; Bessell PR; Barreaux A; Solano P; Crowley EH; Rock KS; Jamonneau V
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011514. PubMed ID: 37523361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients.
    Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V
    Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural progression of Gambiense sleeping sickness: what is the evidence?
    Checchi F; Filipe JA; Barrett MP; Chandramohan D
    PLoS Negl Trop Dis; 2008; 2(12):e303. PubMed ID: 19104656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
    Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
    Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed infections of trypanosomes in tsetse and pigs and their epidemiological significance in a sleeping sickness focus of Côte d'Ivoire.
    Jamonneau V; Ravel S; Koffi M; Kaba D; Zeze DG; Ndri L; Sane B; Coulibaly B; Cuny G; Solano P
    Parasitology; 2004 Dec; 129(Pt 6):693-702. PubMed ID: 15648692
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
    Elife; 2017 May; 6():. PubMed ID: 28537557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Trypanosoma brucei circulating in a sleeping sickness focus in Côte d'Ivoire: assessment of genotype selection by the isolation method.
    Jamonneau V; Barnabé C; Koffi M; Sané B; Cuny G; Solano P
    Infect Genet Evol; 2003 Jul; 3(2):143-9. PubMed ID: 12809809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population structure of Trypanosoma brucei S. L. in Cote d'Ivoire assayed by multilocus enzyme electrophoresis: epidemiological and taxonomical considerations.
    Penchenier L; Mathleu-Daudé F; Brengues C; Bañuls AL; Tibayrenc M
    J Parasitol; 1997 Feb; 83(1):19-22. PubMed ID: 9057691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive surveillance of human African trypanosomiasis in Côte d'Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics.
    Koné M; Kaba D; Kaboré J; Thomas LF; Falzon LC; Koffi M; Kouamé CM; Ahouty B; Compaoré CFA; N'Gouan EK; Solano P; Fèvre E; Büscher P; Lejon V; Jamonneau V
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009656. PubMed ID: 34460829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complex health seeking pathway of a human African trypanosomiasis patient in Côte d'Ivoire underlines the need of setting up passive surveillance systems.
    Koné M; N'Gouan EK; Kaba D; Koffi M; Kouakou L; N'Dri L; Kouamé CM; Nanan VK; Tapé GA; Coulibaly B; Courtin F; Ahouty B; Djohan V; Bucheton B; Solano P; Büscher P; Lejon V; Jamonneau V
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008588. PubMed ID: 32925917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitaemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population.
    Garcia A; Jamonneau V; Magnus E; Laveissière C; Lejon V; N'Guessan P; N'Dri L; Van Meirvenne N; Büscher P
    Trop Med Int Health; 2000 Nov; 5(11):786-93. PubMed ID: 11123826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage migrating inhibitory factor expression is associated with Trypanosoma brucei gambiense infection and is controlled by trans-acting expression quantitative trait loci in the Guinean population.
    Kaboré JW; Camara O; Ilboudo H; Capewell P; Clucas C; Cooper A; Kaboré J; Camara M; Jamonneau V; Hertz-Fowler C; Bélem AMG; Matovu E; Macleod A; Sidibé I; Noyes H; Bucheton B;
    Infect Genet Evol; 2019 Jul; 71():108-115. PubMed ID: 30914286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease.
    Madhavan SM; O'Toole JF
    Clin Exp Nephrol; 2014 Apr; 18(2):238-42. PubMed ID: 24233469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between human African trypanosomiasis and the IL6 gene in a Congolese population.
    Courtin D; Milet J; Jamonneau V; Yeminanga CS; Kumeso VK; Bilengue CM; Betard C; Garcia A
    Infect Genet Evol; 2007 Jan; 7(1):60-8. PubMed ID: 16720107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.
    Jamonneau V; Ilboudo H; Kaboré J; Kaba D; Koffi M; Solano P; Garcia A; Courtin D; Laveissière C; Lingue K; Büscher P; Bucheton B
    PLoS Negl Trop Dis; 2012; 6(6):e1691. PubMed ID: 22720107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.
    Capewell P; Clucas C; DeJesus E; Kieft R; Hajduk S; Veitch N; Steketee PC; Cooper A; Weir W; MacLeod A
    PLoS Pathog; 2013; 9(10):e1003686. PubMed ID: 24098129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies].
    Kambiré R; Lingué K; Courtin F; Sidibé I; Kiendrébéogo D; N'gouan KE; Blé L; Kaba D; Koffi M; Solano P; Bucheton B; Jamonneau V
    Parasite; 2012 Nov; 19(4):389-96. PubMed ID: 23193524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa.
    Koffi M; De Meeûs T; Bucheton B; Solano P; Camara M; Kaba D; Cuny G; Ayala FJ; Jamonneau V
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):209-14. PubMed ID: 19106297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of parasitological methods for the diagnosis of gambian trypanosomiasis in an area of low endemicity in Côte d'Ivoire.
    Truc P; Bailey JW; Doua F; Laveissière C; Godfrey DG
    Trans R Soc Trop Med Hyg; 1994; 88(4):419-21. PubMed ID: 7570825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.